Omnicell Company Profile (NASDAQ:OMCL)

About Omnicell

Omnicell logoOmnicell, Inc. (Omnicell) is a provider of automation and business information solutions designed to enable healthcare systems to streamline the medication administration process and manage medical supplies for increased operational efficiency and enhanced patient safety. The Company operates through two operating segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment organizes the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems, and related software. The Medication Adherence segment primarily includes the manufacturing and selling of consumable medication blister cards, packaging equipment and ancillary products and services. Its product line includes OmniRx, SinglePointe, AnywhereRN, Omnicell and Pandora Data Analytics, Savvy Mobile Medication System, Central Pharmacy and Satellite Pharmacy Manager, Anesthesia Workstation and Advanced Interoperability products.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Healthcare Information Services
  • Sub-Industry: Health Care Technology
  • Exchange: NASDAQ
  • Symbol: OMCL
  • CUSIP: 68213N10
Key Metrics:
  • Previous Close: $38.15
  • 50 Day Moving Average: $35.63
  • 200 Day Moving Average: $35.63
  • 52-Week Range: $25.06 - $40.50
  • Trailing P/E Ratio: 2244.12
  • Foreward P/E Ratio: 18.43
  • P/E Growth: 1.70
  • Market Cap: $1.39B
  • Outstanding Shares: 36,553,000
  • Beta: 0.76
Profitability:
  • Net Margins: 1.24%
  • Return on Equity: 10.74%
  • Return on Assets: 5.31%
Debt:
  • Debt-to-Equity Ratio: 0.50%
  • Current Ratio: 1.70%
  • Quick Ratio: 1.33%
Additional Links:
Companies Related to Omnicell:

Analyst Ratings

Consensus Ratings for Omnicell (NASDAQ:OMCL) (?)
Ratings Breakdown: 1 Hold Rating, 6 Buy Ratings
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $43.71 (14.59% upside)

Analysts' Ratings History for Omnicell (NASDAQ:OMCL)
Show:
DateFirmActionRatingPrice TargetDetails
1/19/2017Dougherty & CoInitiated CoverageBuy$44.00View Rating Details
1/5/2017Cantor FitzgeraldInitiated CoverageOverweight$40.00View Rating Details
12/6/2016Benchmark Co.Boost Price TargetBuy$39.00 -> $55.00View Rating Details
10/27/2016Oppenheimer Holdings, Inc.Set Price TargetBuy$46.00View Rating Details
9/8/2016SidotiDowngradeBuy -> Neutral$43.00View Rating Details
7/29/2016FBR & CoBoost Price TargetOutperform$40.00 -> $41.00View Rating Details
3/21/2016Topeka Capital MarketsLower Price TargetBuy$38.00 -> $37.00View Rating Details
2/5/2016Piper Jaffray CompaniesLower Price TargetOverweight$42.00 -> $35.00View Rating Details
11/1/2015Cowen and CompanyReiterated RatingMarket Perform$37.00 -> $29.00View Rating Details
6/18/2015StephensInitiated CoverageOutperform$44.00View Rating Details
5/9/2015Craig HallumReiterated RatingBuy$42.00View Rating Details
(Data available from 2/26/2015 forward)

Earnings

Earnings History for Omnicell (NASDAQ:OMCL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/26/2017        
2/15/2017Q4 2016$0.41$0.37$181.53 millionViewListenView Earnings Details
10/27/2016Q316$0.41$0.40$179.75 million$179.40 millionViewListenView Earnings Details
7/28/2016Q216$0.32$0.38$170.89 million$175.60 millionViewListenView Earnings Details
4/28/2016Q116$0.26$0.35$167.18 million$171.00 millionViewListenView Earnings Details
2/4/2016Q415$0.39$0.40$126.89 million$130.30 millionViewListenView Earnings Details
10/29/2015Q315$0.36$0.36$128.50 million$125.20 millionViewListenView Earnings Details
7/30/2015Q215$0.32$0.28$121.35 million$112.80 millionViewListenView Earnings Details
4/30/2015Q115$0.23$0.29$112.00 million$16.20 millionViewN/AView Earnings Details
2/3/2015Q414$0.33$0.39$114.65 million$121.50 millionViewListenView Earnings Details
10/30/2014Q314$0.31$0.30$106.10 million$112.50 millionViewListenView Earnings Details
7/31/2014Q214$0.29$0.30$103.23 million$105.10 millionViewListenView Earnings Details
5/1/2014Q114$0.24$0.26$97.49 million$101.80 millionViewListenView Earnings Details
2/4/2014Q413$0.28$0.29$101.13 million$105.80 millionViewListenView Earnings Details
10/31/2013Q313$0.28$0.31$94.96 million$94.03 millionViewN/AView Earnings Details
8/1/2013Q2 2013$0.25$0.27$92.42 million$93.70 millionViewN/AView Earnings Details
5/2/2013Q1 2013$0.19$0.21$87.20 million$87.11 millionViewN/AView Earnings Details
1/31/2013Q4 2012$0.25$0.25$87.31 million$90.16 millionViewN/AView Earnings Details
10/25/2012$0.22$0.29ViewN/AView Earnings Details
8/1/2012$0.18$0.20ViewN/AView Earnings Details
5/2/2012$0.13$0.13ViewN/AView Earnings Details
1/26/2012$0.16$0.19ViewN/AView Earnings Details
10/27/2011$0.16$0.16ViewN/AView Earnings Details
7/28/2011$0.13$0.15ViewN/AView Earnings Details
5/2/2011$0.10$0.11ViewN/AView Earnings Details
1/27/2011$0.12$0.11ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Omnicell (NASDAQ:OMCL)
Current Year EPS Consensus Estimate: $1.36 EPS
Next Year EPS Consensus Estimate: $2.07 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.24$0.24$0.24
Q2 20161$0.21$0.21$0.21
Q3 20161$0.31$0.31$0.31
Q4 20161$0.38$0.38$0.38
Q2 20171$0.12$0.12$0.12
Q4 20171$0.32$0.32$0.32
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Omnicell (NASDAQ:OMCL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Omnicell (NASDAQ:OMCL)
Insider Ownership Percentage: 3.75%
Institutional Ownership Percentage: 94.34%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/21/2017Sara J WhiteDirectorSell3,443$38.06$131,040.58View SEC Filing  
11/18/2016Dan S JohnstonEVPSell8,850$33.65$297,802.50View SEC Filing  
11/18/2016Jorge R TaborgaVPSell2,068$33.66$69,608.88View SEC Filing  
11/8/2016J Christopher DrewVPSell20,000$31.95$639,000.00View SEC Filing  
9/12/2016Gary S PetersmeyerDirectorSell2,000$37.98$75,960.00View SEC Filing  
9/8/2016Gary S PetersmeyerDirectorSell2,400$39.39$94,536.00View SEC Filing  
9/6/2016Gary S PetersmeyerDirectorSell2,000$39.02$78,040.00View SEC Filing  
9/2/2016Gary S PetersmeyerDirectorSell3,000$38.52$115,560.00View SEC Filing  
8/19/2016Dan S JohnstonEVPSell8,850$36.93$326,830.50View SEC Filing  
8/19/2016Jorge R TaborgaVPSell1,778$36.92$65,643.76View SEC Filing  
8/11/2016Randall A LippsChairmanSell37,425$37.37$1,398,572.25View SEC Filing  
8/9/2016J Christopher DrewVPSell15,000$37.89$568,350.00View SEC Filing  
8/9/2016James T JudsonDirectorSell6,250$37.98$237,375.00View SEC Filing  
8/4/2016Gary S PetersmeyerDirectorSell8,750$37.84$331,100.00View SEC Filing  
7/29/2016Jorge R TaborgaVPSell10,023$40.00$400,920.00View SEC Filing  
7/6/2016Robin Gene SeimEVPSell5,302$34.75$184,244.50View SEC Filing  
7/1/2016Robin Gene SeimEVPSell3,645$35.00$127,575.00View SEC Filing  
6/6/2016Jorge R TaborgaVPSell25,979$33.00$857,307.00View SEC Filing  
5/24/2016Gary S PetersmeyerDirectorSell6,250$31.22$195,125.00View SEC Filing  
5/20/2016Dan S JohnstonEVPSell8,850$30.73$271,960.50View SEC Filing  
5/20/2016Jorge R TaborgaVPSell1,933$30.73$59,401.09View SEC Filing  
5/10/2016J Christopher DrewVPSell15,000$31.63$474,450.00View SEC Filing  
5/5/2016Sara J WhiteDirectorSell2,000$31.76$63,520.00View SEC Filing  
4/29/2016Robin Gene SeimEVPSell6,407$31.00$198,617.00View SEC Filing  
4/26/2016Jorge R TaborgaVPSell23,827$30.00$714,810.00View SEC Filing  
4/26/2016Robin Gene SeimEVPSell767$30.00$23,010.00View SEC Filing  
2/19/2016Dan S JohnstonEVPSell8,850$27.41$242,578.50View SEC Filing  
2/19/2016Jorge R TaborgaVPSell1,685$27.42$46,202.70View SEC Filing  
2/11/2016Randall A. LippsCEOSell40,000$27.81$1,112,400.00View SEC Filing  
2/9/2016J Christopher DrewVPSell15,000$27.57$413,550.00View SEC Filing  
12/18/2015Nhat H. NgoVPSell4,069$28.71$116,820.99View SEC Filing  
11/17/2015Dan S. JohnstonVPSell2,500$28.00$70,000.00View SEC Filing  
11/10/2015J Christopher DrewVPSell25,000$26.79$669,750.00View SEC Filing  
11/9/2015Dan S. JohnstonVPSell2,700$27.29$73,683.00View SEC Filing  
10/13/2015Gary S. PetersmeyerDirectorSell670$31.66$21,212.20View SEC Filing  
8/13/2015Robin Gene SeimCFOSell23,946$35.63$853,195.98View SEC Filing  
7/1/2015Robin Gene SeimCFOSell19,582$37.84$740,982.88View SEC Filing  
6/17/2015Nhat H NgoVPSell4,067$38.78$157,718.26View SEC Filing  
6/2/2015James T JudsonDirectorSell8,032$36.83$295,818.56View SEC Filing  
6/2/2015Nhat H NgoVPSell6,375$36.80$234,600.00View SEC Filing  
5/26/2015Sara J WhiteDirectorSell4,000$36.25$145,000.00View SEC Filing  
5/7/2015Dan S JohnstonVPSell7,715$34.25$264,238.75View SEC Filing  
2/12/2015J Christopher DrewVPSell25,000$34.62$865,500.00View SEC Filing  
2/6/2015Dan S JohnstonVPSell6,552$33.29$218,116.08View SEC Filing  
2/2/2015James T JudsonDirectorSell5,000$31.61$158,050.00View SEC Filing  
1/13/2015Gary S PetersmeyerDirectorSell670$31.31$20,977.70View SEC Filing  
1/2/2015James T JudsonDirectorSell5,000$32.36$161,800.00View SEC Filing  
1/2/2015Robin Gene SeimCFOSell1,948$32.36$63,037.28View SEC Filing  
12/17/2014Marga Ortigas-WedekindVPSell4,080$32.20$131,376.00View SEC Filing  
12/15/2014Gary S PetersmeyerDirectorSell670$33.25$22,277.50View SEC Filing  
12/8/2014Nhat H NgoVPSell1,754$32.89$57,689.06View SEC Filing  
12/1/2014James T JudsonDirectorSell5,000$31.94$159,700.00View SEC Filing  
11/12/2014Randy D LindholmDirectorSell5,000$31.72$158,600.00View SEC Filing  
11/11/2014J Christopher DrewVPSell37,500$31.86$1,194,750.00View SEC Filing  
11/7/2014Dan S JohnstonVPSell27,625$31.74$876,817.50View SEC Filing  
11/3/2014James T JudsonDirectorSell5,000$32.27$161,350.00View SEC Filing  
10/3/2014Nhat H NgoVPSell2,275$28.00$63,700.00View SEC Filing  
10/1/2014James T JudsonDirectorSell5,000$27.02$135,100.00View SEC Filing  
9/15/2014Jorge R TaborgaVPSell944$26.37$24,893.28View SEC Filing  
9/15/2014Robin Gene SeimCFOSell9,347$26.32$246,013.04View SEC Filing  
9/2/2014James T JudsonDirectorSell5,000$28.18$140,900.00View SEC Filing  
9/2/2014Robin Gene SeimCFOSell27,500$28.19$775,225.00View SEC Filing  
8/26/2014Dan S JohnstonVPSell6,250$28.00$175,000.00View SEC Filing  
8/26/2014James T JudsonDirectorSell9,913$27.91$276,671.83View SEC Filing  
7/9/2014Robin Gene SeimCFOSell2,442$28.21$68,888.82View SEC Filing  
7/1/2014James T JudsonDirectorSell5,000$29.28$146,400.00View SEC Filing  
6/26/2014Marga Ortigas-WedekindVPSell2,961$28.17$83,411.37View SEC Filing  
6/25/2014Nhat H NgoVPSell2,274$28.00$63,672.00View SEC Filing  
6/17/2014Nhat H NgoVPSell1,420$27.70$39,334.00View SEC Filing  
6/10/2014Nhat H NgoVPSell1,964$26.38$51,810.32View SEC Filing  
6/2/2014Gary S PetersmeyerDirectorSell5,000$26.45$132,250.00View SEC Filing  
5/21/2014Gary PetersmeyerDirectorSell2,000$26.51$53,020.00View SEC Filing  
5/13/2014J Christopher DrewVPSell37,500$26.08$978,000.00View SEC Filing  
5/7/2014Dan JohnstonVPSell4,000$25.25$101,000.00View SEC Filing  
5/1/2014James JudsonDirectorSell5,000$26.24$131,200.00View SEC Filing  
4/8/2014Nhat NgoVPSell1,002$27.40$27,454.80View SEC Filing  
3/18/2014Marga Ortigas-WedekindVPSell5,880$30.00$176,400.00View SEC Filing  
3/18/2014Randall LippsCEOSell124,910$29.89$3,733,559.90View SEC Filing  
12/18/2013Nhat NgoVPSell1,462$24.43$35,716.66View SEC Filing  
12/18/2013Randall LippsCEOSell64,739$24.30$1,573,157.70View SEC Filing  
12/3/2013Dan JohnstonVPSell73,419$23.24$1,706,257.56View SEC Filing  
11/11/2013Randy LindholmDirectorSell3,587$23.00$82,501.00View SEC Filing  
11/7/2013Dan JohnstonVPSell8,000$22.99$183,920.00View SEC Filing  
10/23/2013Robin Gene SeimCFOSell7,664$24.50$187,768.00View SEC Filing  
10/21/2013Robin Gene SeimCFOSell9,349$23.76$222,132.24View SEC Filing  
10/1/2013James T JudsonDirectorSell5,000$23.66$118,300.00View SEC Filing  
9/24/2013Randall LippsCEOSell68,204$25.00$1,705,100.00View SEC Filing  
9/23/2013Marga Ortigas-WedekindVPSell4,000$25.00$100,000.00View SEC Filing  
9/23/2013Randall LippsCEOSell5,083$25.00$127,075.00View SEC Filing  
9/20/2013Robin Gene SeimCFOSell27,500$24.35$669,625.00View SEC Filing  
9/18/2013Randall LippsCEOSell64,453$23.67$1,525,602.51View SEC Filing  
9/4/2013Nhat H NgoVPSell7,362$24.00$176,688.00View SEC Filing  
9/3/2013James JudsonDirectorSell5,000$22.77$113,850.00View SEC Filing  
8/20/2013James JudsonDirectorSell11,724$22.74$266,603.76View SEC Filing  
8/13/2013J Christopher DrewVPSell20,000$22.83$456,600.00View SEC Filing  
8/12/2013Donald WegmillerDirectorSell34,976$22.87$799,901.12View SEC Filing  
8/7/2013Dan JohnstonVPSell8,000$22.92$183,360.00View SEC Filing  
8/6/2013Randall LippsCEOSell5,321$23.00$122,383.00View SEC Filing  
8/2/2013Randall A LippsCEOSell25,000$22.50$562,500.00View SEC Filing  
8/1/2013James JudsonDirectorSell5,000$21.00$105,000.00View SEC Filing  
7/19/2013Nhat H NgoVPSell41,875$21.00$879,375.00View SEC Filing  
7/19/2013Randall A LippsCEOSell5,080$21.00$106,680.00View SEC Filing  
7/1/2013James T JudsonDirectorSell5,000$20.46$102,300.00View SEC Filing  
7/1/2013Robin Gene SeimCFOSell13,032$20.42$266,113.44View SEC Filing  
6/28/2013Marga Ortigas-WedekindVPSell4,545$20.00$90,900.00View SEC Filing  
6/28/2013Randall A LippsCEOSell25,000$20.00$500,000.00View SEC Filing  
6/21/2013Nhat H NgoVPSell3,459$19.01$65,755.59View SEC Filing  
6/18/2013Randall A LippsCEOSell66,378$19.10$1,267,819.80View SEC Filing  
6/10/2013Randy D LindholmDirectorSell23,901$19.14$457,465.14View SEC Filing  
6/4/2013Robin Gene SeimCFOSell25,000$18.72$468,000.00View SEC Filing  
5/22/2013Gary S PetersmeyerDirectorSell2,750$18.10$49,775.00View SEC Filing  
5/16/2013J Christopher DrewVPSell26,000$18.69$485,940.00View SEC Filing  
5/14/2013J Christopher DrewVPSell26,000$18.45$479,700.00View SEC Filing  
5/10/2013Sara J WhiteDirectorSell7,200$18.50$133,200.00View SEC Filing  
5/7/2013Dan S JohnstonVPSell8,000$18.44$147,520.00View SEC Filing  
12/3/2012Gary S PetersmeyerDirectorSell1,359$15.17$20,616.03View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Omnicell (NASDAQ:OMCL)
DateHeadline
finance.yahoo.com logoOmnicell: Q4 Report Disappoints, Aesynt Buyout Holds Promise (NASDAQ:OMCL)
finance.yahoo.com - February 24 at 8:48 AM
capitalcube.com logoOmnicell, Inc. :OMCL-US: Earnings Analysis: 2016 By the Numbers : February 22, 2017 (NASDAQ:OMCL)
www.capitalcube.com - February 22 at 7:07 PM
marketexclusive.com logoInsider Trading Activity Omnicell, Inc. (NASDAQ:OMCL) – Director Sold 3,443 shares of Stock (NASDAQ:OMCL)
marketexclusive.com - February 22 at 9:05 AM
finance.yahoo.com logoInova Partners with Omnicell to Enhance Pharmacy Supply Chain Strategy (NASDAQ:OMCL)
finance.yahoo.com - February 21 at 5:52 PM
capitalcube.com logoOmnicell, Inc. :OMCL-US: Earnings Analysis: Q4, 2016 By the Numbers : February 21, 2017 (NASDAQ:OMCL)
www.capitalcube.com - February 21 at 5:52 PM
News IconFollowing the Numbers for Omnicell, Inc. (NASDAQ:OMCL) - Benton Bulletin (NASDAQ:OMCL)
bentonbulletin.com - February 17 at 8:12 AM
News IconWhat Investors Should Know About Omnicell Inc’s (OMCL) Financial Strength? (NASDAQ:OMCL)
simplywall.st - February 16 at 6:36 PM
News IconWhat Investors Should Know About Omnicell Inc’s (OMCL) Financial Strength? (NASDAQ:OMCL)
simplywall.st - February 16 at 6:36 PM
seekingalpha.com logoOmnicell's (OMCL) CEO Randall Lipps on Q4 2016 Results - Earnings Call Transcript (NASDAQ:OMCL)
seekingalpha.com - February 16 at 6:36 PM
seekingalpha.com logoOmnicell's (OMCL) CEO Randall Lipps on Q4 2016 Results - Earnings Call Transcript (NASDAQ:OMCL)
seekingalpha.com - February 16 at 6:36 PM
investing.com logoOmnicell, Inc.Shares Fall On Lower Than Expected Earnings (NASDAQ:OMCL)
www.investing.com - February 16 at 6:36 PM
investing.com logoOmnicell, Inc.Shares Fall On Lower Than Expected Earnings (NASDAQ:OMCL)
www.investing.com - February 16 at 6:36 PM
biz.yahoo.com logoQ4 2016 Omnicell Inc Earnings Release - After Market Close (NASDAQ:OMCL)
us.rd.yahoo.com - February 16 at 6:36 PM
biz.yahoo.com logoQ4 2016 Omnicell Inc Earnings Release - After Market Close (NASDAQ:OMCL)
us.rd.yahoo.com - February 16 at 6:36 PM
us.rd.yahoo.com logoOmnicell Reports Results for Fiscal Year and Fourth Quarter 2016 (NASDAQ:OMCL)
us.rd.yahoo.com - February 16 at 6:36 PM
us.rd.yahoo.com logoOmnicell Reports Results for Fiscal Year and Fourth Quarter 2016 (NASDAQ:OMCL)
us.rd.yahoo.com - February 16 at 6:36 PM
us.rd.yahoo.com logo4:05 pm Omnicell misses by $0.04, misses on revs; guides Q1 EPS below consensus, revs below consensus; guides FY17 EPS below consensus, revs below consensus (NASDAQ:OMCL)
us.rd.yahoo.com - February 16 at 6:36 PM
us.rd.yahoo.com logo4:05 pm Omnicell misses by $0.04, misses on revs; guides Q1 EPS below consensus, revs below consensus; guides FY17 EPS below consensus, revs below consensus (NASDAQ:OMCL)
us.rd.yahoo.com - February 16 at 6:36 PM
biz.yahoo.com logoOMNICELL, INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities (NASDAQ:OMCL)
us.rd.yahoo.com - February 16 at 6:36 PM
biz.yahoo.com logoOMNICELL, INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities (NASDAQ:OMCL)
us.rd.yahoo.com - February 16 at 6:36 PM
sg.finance.yahoo.com logoOmnicell misses Street 4Q forecasts (NASDAQ:OMCL)
us.rd.yahoo.com - February 16 at 6:36 PM
sg.finance.yahoo.com logoOmnicell misses Street 4Q forecasts (NASDAQ:OMCL)
us.rd.yahoo.com - February 16 at 6:36 PM
us.rd.yahoo.com logoEdited Transcript of OMCL earnings conference call or presentation 15-Feb-17 9:30pm GMT (NASDAQ:OMCL)
us.rd.yahoo.com - February 16 at 6:36 PM
News IconOmnicell, Inc. (OMCL) earnings reaction history in focus - Post Analyst (NASDAQ:OMCL)
postanalyst.com - February 16 at 6:36 PM
us.rd.yahoo.com logoEdited Transcript of OMCL earnings conference call or presentation 15-Feb-17 9:30pm GMT (NASDAQ:OMCL)
us.rd.yahoo.com - February 16 at 6:36 PM
us.rd.yahoo.com logoOmnicell Launches Innovative Medication Adherence Automated Pharmacy Solution to Increase Pharmacy Efficiency and Profitability (NASDAQ:OMCL)
us.rd.yahoo.com - February 14 at 10:28 PM
prnewswire.com logoDCH Health System Partners with Omnicell to Automate Sterile Compounding with ... (NASDAQ:OMCL)
www.prnewswire.com - February 13 at 8:14 PM
finance.yahoo.com logoOmnicell Medication Management Solutions and Interoperability Featured at HIMSS17 with Real World Application in Interoperability Showcase (NASDAQ:OMCL)
finance.yahoo.com - February 13 at 8:14 PM
biz.yahoo.com logoOMNICELL, INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (NASDAQ:OMCL)
biz.yahoo.com - February 13 at 8:14 PM
finance.yahoo.com logoDCH Health System Partners with Omnicell to Automate Sterile Compounding with Robotic IV Insourcing Solution (RIIS) (NASDAQ:OMCL)
finance.yahoo.com - February 13 at 9:34 AM
marketnewsvideo.com logoOmnicell Stock Sees Short Interest Increase 12.2% (NASDAQ:OMCL)
www.marketnewsvideo.com - February 10 at 7:57 PM
News IconStock Update: Looking at the Levels for Omnicell, Inc. (NASDAQ:OMCL) - Midway Monitor (NASDAQ:OMCL)
midwaymonitor.com - February 9 at 5:59 AM
nasdaq.com logoMondrian Investment Partners LTD Buys Wells Fargo, Walgreens Boots Alliance, SK Telecom Co, ... (NASDAQ:OMCL)
www.nasdaq.com - February 4 at 7:00 PM
finance.yahoo.com logoOmnicell to Release Fourth Quarter 2016 Earnings Results on February 15th (NASDAQ:OMCL)
finance.yahoo.com - February 2 at 7:57 PM
News IconShare Focus: Checking the Indicators on Omnicell Inc. (OMCL) - Market Point (NASDAQ:OMCL)
mtptnews.com - January 31 at 8:01 PM
4-traders.com logoOmnicell : Showcases New XT Series Automated Dispensing System at the Arab Health Exhibition and Congress - Press Release issued by Omnicell, Inc. (NASDAQ:OMCL)
www.4-traders.com - January 30 at 7:43 PM
tmcnet.com logoOmnicell Showcases New XT Series Automated Dispensing System at the Arab Health Exhibition and Congress (NASDAQ:OMCL)
www.tmcnet.com - January 30 at 8:45 AM
News IconVC Score In Focus for Omnicell, Inc. (NASDAQ:OMCL) - The Tribune (NASDAQ:OMCL)
lakecitytribune.com - January 28 at 7:09 PM
News IconChart Level Analysis on Shares of Omnicell Inc. (OMCL) - Market Point (NASDAQ:OMCL)
mtptnews.com - January 28 at 5:28 AM
News IconFollowing the Numbers on Shares of Omnicell, Inc. (NASDAQ:OMCL) - The Tribune (NASDAQ:OMCL)
lakecitytribune.com - January 28 at 5:28 AM
News IconWith Markets Booming Higher, Is This Stock Fairly Valued: Omnicell, Inc. (NASDAQ:OMCL) - Aiken Advocate (NASDAQ:OMCL)
aikenadvocate.com - January 27 at 12:07 AM
News IconEarnings in Full Force, Analysts Take Aim at Omnicell, Inc. (NASDAQ:OMCL) - Wall Street Beacon (NASDAQ:OMCL)
wsbeacon.com - January 27 at 12:07 AM
News IconMarket Scope: F-Score and Volatility Review for Omnicell, Inc. (NASDAQ:OMCL) - The Tribune (NASDAQ:OMCL)
lakecitytribune.com - January 24 at 7:48 PM
News IconInvestor Arena: Keeping an Eye on Omnicell Inc. (OMCL) - Market Point (NASDAQ:OMCL)
mtptnews.com - January 24 at 7:48 PM
finance.yahoo.com logoWellStar Health System Selects Omnicell's Medication Management Solutions to Promote EHR Interoperability and Medication Security (NASDAQ:OMCL)
finance.yahoo.com - January 24 at 9:01 AM
News IconChart Inspection on Shares of Omnicell Inc. (OMCL) - Springdale Times (NASDAQ:OMCL)
springdaletimes.com - January 21 at 7:39 AM
seekingalpha.com logoOmnicell perks up 4% on Dougherty upgrade - Seeking Alpha (NASDAQ:OMCL)
seekingalpha.com - January 21 at 7:39 AM
capitalcube.com logoOmnicell, Inc. breached its 50 day moving average in a Bullish Manner : OMCL-US : January 20, 2017 (NASDAQ:OMCL)
www.capitalcube.com - January 20 at 7:49 PM
finance.yahoo.com logoCoverage initiated on Omnicell by Dougherty & Company (NASDAQ:OMCL)
finance.yahoo.com - January 19 at 11:39 PM
seekingalpha.com logoOmnicell perks up 4% on Dougherty upgrade (NASDAQ:OMCL)
seekingalpha.com - January 19 at 4:06 PM

Social

What is Omnicell's stock symbol?

Omnicell trades on the NASDAQ under the ticker symbol "OMCL."

Where is Omnicell's stock going? Where will Omnicell's stock price be in 2017?

7 equities research analysts have issued 12-month price objectives for Omnicell's shares. Their predictions range from $37.00 to $55.00. On average, they expect Omnicell's share price to reach $43.71 in the next twelve months.

When will Omnicell announce their earnings?

Omnicell is scheduled to release their next quarterly earnings announcement on Wednesday, April, 26th 2017.

Who owns Omnicell stock?

Omnicell's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Dimensional Fund Advisors LP (4.93%), Champlain Investment Partners LLC (4.38%), State Street Corp (2.20%), Thrivent Financial for Lutherans (1.67%), Edge Asset Management Inc. (1.08%) and Westwood Holdings Group Inc. (1.03%). Company insiders that own Omnicell stock include Dan S Johnston, Gary S Petersmeyer, J Christopher Drew, James T Judson, Jorge R Taborga, Nhat H Ngo, Randall A Lipps, Robin Gene Seim and Sara J White.

Who sold Omnicell stock? Who is selling Omnicell stock?

Omnicell's stock was sold by a variety of institutional investors in the last quarter, including Allianz Asset Management AG, Axiom International Investors LLC DE, State Board of Administration of Florida Retirement System, Nicholas Co. Inc. WI, Teachers Retirement System of The State of Kentucky, Edge Asset Management Inc., Kopp Investment Advisors LLC and Lyon Street Capital LLC. Company insiders that have sold Omnicell stock in the last year include Dan S Johnston, Gary S Petersmeyer, J Christopher Drew, James T Judson, Jorge R Taborga, Randall A Lipps, Robin Gene Seim and Sara J White.

Who bought Omnicell stock? Who is buying Omnicell stock?

Omnicell's stock was bought by a variety of institutional investors in the last quarter, including Champlain Investment Partners LLC, Westwood Holdings Group Inc., State Street Corp, Martingale Asset Management L P, Russell Investments Group Ltd., Dimensional Fund Advisors LP, Bessemer Group Inc. and Renaissance Technologies LLC.

How do I buy Omnicell stock?

Shares of Omnicell can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Omnicell stock cost?

One share of Omnicell stock can currently be purchased for approximately $38.15.

Omnicell (NASDAQ:OMCL) Chart for Sunday, February, 26, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Omnicell (NASDAQ:OMCL)

Earnings History Chart

Earnings by Quarter for Omnicell (NASDAQ:OMCL)

Dividend History Chart

Dividend Payments by Quarter for Omnicell (NASDAQ:OMCL)

Last Updated on 2/26/2017 by MarketBeat.com Staff